Statement of Principles concerning chronic pancreatitis (Balance of Probabilities) (No. 65 of 2020)

The instrument revolves around seven core concepts, each defined or implied in the text.

First, chronic pancreatitis itself is defined in section 7(2) as a progressive inflammatory disease causing irreversible morphological change with parenchymal damage and fibrosis. This excludes reversible pancreatic inflammation, minimal‑change disease, and early‑stage acute pancreatitis unless it later satisfies this definition. The note adds typical presentations: abdominal pain, malnutrition, and loss of exocrine and endocrine function. The ICD‑10‑AM codes (K86.0 and K86.1) are referenced only for administrative matching; the clinical definition prevails.

Second, relevant service is defined in the dictionary as eligible war service (other than operational service) under the VEA, defence service (other than hazardous service and British nuclear test defence service) under the VEA, or peacetime service under the MRCA. This is narrower than the full range of service covered under the VEA. Operational service and hazardous service are excluded from this SoP because they use the reasonable‑hypothesis standard under separate provisions; different SoPs may apply to them.

Third, the factors in section 9 are the core causal pathways. They include smoking at least 20 pack‑years before onset and within ten years of cessation; consuming at least 90 kilograms of alcohol within any five‑year period before onset and within five years of cessation; therapeutic radiation to the pancreas at least two years before onset; ductal obstruction; cholelithiasis; hyperparathyroidism; hypertriglyceridaemia with a specific threshold above 11.3 millimoles per litre; an episode of acute pancreatitis; and inability to obtain appropriate clinical management. Each factor has temporal or quantitative thresholds that must be met.

Fourth, pack‑year is a quantifier of cumulative tobacco exposure. The 2022 amendment replaced the previous definition with a standardised metric: one pack‑year equals 20 cigarettes per day for one year, or 7,300 grams of smoking tobacco by weight. This makes conversion across different tobacco products (cigarettes, pipe, cigars, combinations) possible by weight equivalence. The note provides the formula: pack‑years = (cigarettes per day / 20) multiplied by years. This is a critical evidentiary tool because many claimants may have smoked irregularly or used multiple forms of tobacco; proving precisely 20 pack‑years requires reconstructing habit history, which can be difficult decades later.

Fifth, alcohol consumption is defined in terms of cumulative mass (90 kilograms) within any five‑year window, using the Australian Standard of ten grams of alcohol per standard drink. This is a high threshold: 90,000 grams divided by 10 grams per drink equals 9,000 standard drinks in five years, or about 4.9 drinks per day on average. The SoP does not require continuous heavy drinking; a five‑year binge period is sufficient, but the burden is on the claimant to prove the cumulative intake.

Sixth, the concept of clinical onset is central but not defined in the instrument. It is a term of art used across SoPs, referring to the time when a person first seeks medical attention for symptoms or when the disease becomes clinically apparent. The SoP uses the phrase “before the clinical onset” for most factors, and “at the time of the clinical onset” for obstruction, cholelithiasis, hyperparathyroidism, and hypertriglyceridaemia. This distinction matters: for smoking and alcohol, the factor must have occurred in the past and then ceased (or continued) before the disease becomes evident. For the anatomical and metabolic factors, they must be present contemporaneously with the onset.

Seventh, the relationship to service requirement in section 10: even if a factor exists, it must be related to the person’s relevant service. This means the factor itself must have arisen from service. For example, heavy smoking that started after service and is not attributable to service cannot be used to connect pancreatitis, even if the pack‑year threshold is met. Factor 9(9) (inability to obtain appropriate clinical management) is special: it only applies to material contribution to or aggravation of pancreatitis that was already suffered before or during service but did not arise out of service.

The SoP directly affects three categories of claimants: veterans under the VEA with eligible war service (other than operational service) or defence service (other than hazardous service or British nuclear test service), and members under the MRCA with peacetime service. It does not apply to those with operational service or hazardous service, who instead face the reasonable‑hypothesis standard under different SoPs or the alternative test under section 120(1) of the VEA. The instrument therefore segments the veteran population by service type, creating different evidentiary pathways for the same disease depending on the character of service.

By extension, the SoP affects the Department of Veterans’ Affairs (DVA) as the decision‑maker, and the Repatriation Medical Authority as the issuing body. DVA delegates must apply the SoP rigorously; they cannot accept a medical opinion that asserts a causal connection based on a factor not listed, unless the factor falls within the “inability to obtain appropriate clinical management” exception or the cross‑reference mechanism in section 11. That section allows factors referring to another injury or disease covered by another SoP to be applied in accordance with that other SoP. For example, if chronic pancreatitis is caused by a drug reaction that in turn is linked to service via another SoP, the chain may work, but the instrument does not list drug reactions directly.

Legal practitioners representing veterans must know the SoP’s thresholds precisely. A missed pack‑year calculation can lose a claim. Medical specialists who provide reports need to frame their opinions in the language of the factors, specifying whether the pancreas was in the field of radiation, whether triglyceride levels exceeded the threshold, or whether ductal obstruction was present. The SoP incentivises thorough medical documentation during service; if a service medical record notes cholelithiasis or hypertriglyceridaemia, that can be used years later. Conversely, the absence of such records can block a claim.

The instrument also affects the broader healthcare system indirectly. Because the SoP sets a high threshold for alcohol consumption (90 kg in five years), claimants who drank heavily but cannot prove the cumulative amount may be denied compensation. This may shift costs to public hospitals or the National Disability Insurance Scheme if the pancreatitis leads to disability and the person cannot access DVA support. Similarly, the smoking threshold (20 pack‑years) excludes lighter smokers who nonetheless develop chronic pancreatitis. From an economic perspective, the SoP concentrates the compensable population into those with very heavy substance use or specific medical conditions, potentially creating a perverse incentive for claimants to exaggerate or reconstruct consumption histories.

Finally, the instrument affects the RMA itself as a precedent for future SoPs. The definition of pack‑year and the method of calculating alcohol by mass rather than by drink‑years could be replicated in other SoPs for alcohol‑related diseases, spreading compliance complexity across multiple conditions.

The SoP does not impose duties on private persons in the usual sense; it is a determination that binds decision‑makers. The primary duty rests on the Repatriation Medical Authority to base the SoP on sound medical‑scientific evidence, as stated in section 8. That duty is declared, not justiciable in litigation (the RMA’s opinion is conclusive unless it acted unreasonably). The authority also has the duty to amend the SoP when new evidence emerges, as seen with the 2022 amendment to the pack‑year definition.

For claimants, the key right is the ability to have a claim assessed using the factors as presumptive pathways. If a claimant proves a factor, the decision‑maker must treat the condition as related to service, subject to the relationship requirement under section 10. This is a right to a rebuttable presumption. Claimants also have the right to rely on cross‑referenced SoPs under section 11, which can incorporate additional factors from other instruments. Practically, this means a claimant with both chronic pancreatitis and another service‑linked condition may combine pathways.

Claimants have a duty to provide evidence that substantiates the factor. For factor 9(1), the claimant must prove the cumulative tobacco consumption and the date of cessation (if applicable) and show that clinical onset occurred within ten years of cessation. That imposes a record‑keeping duty: the claimant must have or reconstruct reliable evidence of decades‑old behaviour. For factor 9(2), the claimant must prove the quantity of alcohol consumed and the five‑year window. This is notoriously difficult; few people keep diaries of alcohol intake. The SoP does not specify acceptable types of evidence, but DVA policy guides often accept self‑reports supported by corroborating history.

Claimants also have a duty to prove the chronological relationship. For smoking and alcohol, the onset must occur within a specific period after cessation. If the claimant stopped smoking 15 years before onset, the factor fails unless they can rely on another factor. The temporal requirements are strict; the SoP does not provide any discretion to extend the window based on individual variation.

If none of the primary factors apply, the claimant may attempt to use factor 9(9): inability to obtain appropriate clinical management. This factor has a narrower operation: it applies only to material contribution to or aggravation of pre‑existing chronic pancreatitis, not to cause the condition originally. The duty to prove inability - that appropriate clinical management was not reasonably available as a result of service - rests on the claimant. That might arise, for example, if a veteran was posted to a remote area without access to specialist pancreatic care, causing the disease to worsen. But the instrument does not define “appropriate clinical management”, leaving it to administrative interpretation and potentially leading to disputes.

This instrument contains no penalty provisions. As a legislative instrument made under the VEA, it does not create offences. Enforcement is not in the criminal sense; rather, the SoP is enforced through the claims process. If a decision‑maker incorrectly applies the SoP - for example, by ignoring a factor that is made out - the claimant can seek review internally through DVA, then to the Veterans’ Review Board, and then to the Administrative Appeals Tribunal or the Federal Court on questions of law.

The real “penalty” for a claimant who cannot meet a factor is that the claim is refused. That refusal is not punitive; it is the outcome of the statutory test. But the SoP indirectly disciplines behaviour: a claimant who dishonestly claims a factor such as heavy smoking may later face adverse credibility findings and potential fraud investigations under the Criminal Code if the claim for compensation is based on false documents. The VEA itself contains provisions for recovery of overpayments and penalties for false statements (not in this instrument), but the SoP does not address them.

The instrument also provides for the possibility that a factor refers to an injury or disease covered by another SoP (section 11). In that case, the factors in the other SoP apply “in accordance with the terms of that Statement of Principles as in force from time to time”. This creates a dynamic enforcement landscape: if the other SoP is amended or repealed, the reference must be updated. The claimant bears the risk that an amendment narrows the available factors. The endnotes show that the 2022 amendment only changed the definition of pack‑year; that change was likely favourable to claimants because it provided a clearer metric, but any future amendment could be restrictive.

No enforcement body is mentioned. The RMA does not enforce; it only issues SoPs. The DVA is the primary enforcer through its decision‑making. The SoP’s provisions are mandatory, so a decision‑maker who fails to apply them commits an error of law subject to judicial review. That is the only enforcement mechanism.

This SoP is made under subsection 196B(3) of the VEA, which is the provision for balance‑of‑probabilities SoPs. It interacts directly with sections 120B (VEA) and 339 (MRCA), which require decision‑makers to apply relevant SoPs. If no applicable SoP exists, the claim is determined under the general provisions of those Acts. This SoP fills that gap for chronic pancreatitis for non‑operational service.

It also interacts with other SoPs via section 11. If a factor refers to an injury or disease covered by another SoP (for example, “acute pancreatitis” in factor 8), the factors of that other SoP apply. This creates a hierarchical network: a claimant might need to satisfy two SoPs to establish the causal chain. For instance, to prove factor 8 (an episode of acute pancreatitis), the claimant must show that the acute pancreatitis itself is related to service under the acute pancreatitis SoP. The SoP does not list the acute pancreatitis SoP by number, so the relevant instrument must be identified by the decision‑maker. That adds complexity.

The SoP interacts with the Veterans’ Entitlements Act 1986 generally, particularly sections 120 (standard of proof) and 120B (statements of principles). For operational service, section 120(1) applies the reasonable‑hypothesis test; this SoP does not apply there. But the same disease could be claimed under operational service using the general test, even if the SoP factors are not met. The SoP thus creates a two‑tier system: easier claims for heavy smokers under non‑operational service, harder claims for operational service where a reasonable hypothesis must be raised.

The instrument also interacts with the Military Rehabilitation and Compensation Act 2004, sections 335-339. For peacetime service under the MRCA, the SoP is mandatory. For hazardous service or British nuclear test defence service under the VEA, different provisions apply, and this SoP does not cover those.

Finally, the SoP interacts with the Legislation Act 2003 for compilation and amendment procedures. The endnotes show that sections 2 and 4 were repealed under LA sections 48D and 48C, dealing with commencement and automatic repeal of legislative instruments. This is a procedural interaction with no substantive effect on rights.

The instrument does not interact with state workers’ compensation laws, nor with private insurance contracts. It is specific to federal military compensation.

The SoP was originally made on 31 August 2020 as F2020L01105 and commenced on 28 September 2020. It was amended once, by the Veterans’ Entitlements (Statements of Principles,definition of “one pack‑year”) Amendment Determination 2022 (No. 94 of 2022), registered on 26 August 2022, commencing 19 September 2022. The amendment replaced the note under subsection 9(1) and substituted the definition of “one pack‑year” in the dictionary. The original definition is not included in the compilation; the compilation shows the amended text only. The endnote 4 lists the provisions affected: section 2 and 4 were repealed under the Legislation Act, and the pack‑year definition and note were replaced.

The 2022 amendment’s purpose (inferred from the change) was to standardise the calculation of pack‑years across all SoPs. The previous definition of one pack‑year may have used different weight equivalences or omitted the weight method. The new definition explicitly states 7,300 grams of smoking tobacco by weight as an equivalent, and provides the formula for calculation. This reduces ambiguity for claimants who smoked pipe tobacco or cigars, or mixtures. It also aligns the SoP with the general definition used in other instruments, promoting consistency. The amendment also changed the note to subsection 9(1) to refer to the updated dictionary definition.

No other amendments have been made. The instrument is a compilation up to 19 September 2022. It has not been revoked or remade. The RMA may issue a new SoP if the medical evidence changes; if a new SoP is made, this version would be repealed. Until then, it remains in force.

The amendment history highlights the iterative nature of SoPs. The RMA monitors scientific evidence and can fine‑tune definitions without remaking the entire instrument. The 2022 amendment did not alter the substantive factors or thresholds, only the metric for tobacco. This suggests the medical evidence on the carcinogenic or inflammatory potential of tobacco remains consistent, but the measurement tool was refined. From a compliance perspective, the change is favourable to claimants because it clarifies how to prove cumulative exposure for non‑cigarette tobacco.

The instrument text itself provides no litigation history. Endnote 1 notes that uncommenced amendments and modifications are not shown; no court cases are referenced. As a legislative instrument, it may have been the subject of judicial review, but the compilation does not record that. In practice, SoPs are challenged rarely because the RMA’s opinion is given significant deference. The High Court in Repatriation Commission v Gorton (2001) confirmed that the RMA’s determination is binding unless it is irrational or not based on sound medical‑scientific evidence. Challenges typically focus on whether a particular factor is supported by evidence, not on the instrument’s text.

No cases are listed in the source. The deep dive cannot invent any. However, it is worth noting that the lack of litigation may indicate that the instrument is sufficiently clear to avoid disputes, or that claimants accept the factors as inevitable. The rigid thresholds tend to reduce litigation because if a claimant cannot meet the numbers, there is little scope for argument. The only likely litigation is over the definition of “clinical onset” and the calculation of pack‑years or alcohol. The 2022 amendment may reduce disputes over pack‑year calculation by providing a universal formula.

From an economic perspective, the SoP’s clarity may reduce transaction costs (legal fees, delays) because both sides know the rules. But if the thresholds are set too high, claimants may be deterred from bringing claims, saving the government compensation costs at the expense of legitimate claimants. No data is available in the source to test that.

The interaction with other SoPs under section 11 could generate litigation if there is uncertainty about which SoP applies. For example, if a factor refers to “acute pancreatitis” and there are multiple SoPs for pancreatitis (acute vs chronic), a dispute could arise over whether the acute pancreatitis SoP is the correct one. The instrument does not specify by name or number. That is a potential source of future litigation.

Several features of the instrument can trap unwary claimants or their representatives.

Temporal cut‑offs for smoking and alcohol are strict. Factor 9(1) requires onset within ten years of cessation. If a veteran smoked 30 pack‑years but quit at age 40 and developed chronic pancreatitis at age 55, the factor is not met despite the heavy smoking. Similarly, factor 9(2) requires onset within five years of cessation of heavy alcohol consumption. A person who drinks heavily in their 20s but stops and develops pancreatitis 15 years later cannot use that factor. There is no leeway for latency; the SoP is based on the RMA’s view of the epidemiological evidence. Claimants must be careful to document the date of cessation accurately.

The term “clinical onset” is not defined. This creates a loophole: a person might have subclinical pancreatic changes (parenchymal damage on imaging) but no symptoms. The SoP uses “clinical onset”, likely meaning when symptoms first become manifest. If a veteran had a routine CT scan that showed fibrosis but had no pain or malnutrition, the onset date could be earlier than the symptomatic date. The decision‑maker must determine onset based on medical evidence, and that can be disputed. The SoP does not provide a tie‑breaker.

The alcohol factor requires “a cumulative total of at least 90 kilograms of alcohol within any five year period”. The calculation uses the Australian Standard of 10 grams per drink. But the instrument does not define “standard alcoholic drink” for beverages not in standard units, such as home‑brewed beer or spirits. Claimants who drank non‑commercial alcohol may struggle to prove the quantity. Moreover, the five‑year window can be any contiguous 60‑month period; the claimant does not have to identify which five years, but must prove that at some point in life they consumed that amount. DVA may require a consistent pattern rather than a single binge.

For the smoking factor, the 20 pack‑year threshold is high. For a person who smoked 20 cigarettes a day for 20 years, that is exactly 20 pack‑years. If they smoked 15 a day for 30 years, that is 22.5 pack‑years, so it is met. But for a person who smoked 10 a day for 30 years, that is 15 pack‑years, not enough. The definition uses weight equivalence: 7,300 grams per pack‑year. So a person who smoked a pipe consuming 15 grams per day for 40 years would have 60,000 grams or about 8.2 pack‑years, far short. Claimants who used only pipe or cigar tobacco are unlikely to meet the threshold unless they were extremely heavy users. The 2022 amendment made this calculation clearer, but also may have inadvertently excluded some who relied on counting cigarettes from different tobacco types.

Factor 9(4) - ductal obstruction - requires the obstruction to exist “at the time of the clinical onset”. If the obstruction is intermittent or was surgically corrected earlier, it may not satisfy the requirement. Similarly, factor 9(5) (cholelithiasis) and 9(6) (hyperparathyroidism) must be present at onset. If the gallstones were removed years before pancreatitis appeared, the factor fails. The timing requirement is strict.

Factor 9(8) - an episode of acute pancreatitis before onset - does not require that the acute pancreatitis be service‑related. It is simply a medical risk factor. But if the acute pancreatitis itself is not service‑related, the claimant must still show that the factor existed; that is easy. However, the relationship to service requirement in section 10(1) says the factor must be related to relevant service. So if the acute pancreatitis was caused by a civilian event (e.g., gallstones from diet, not service), then the factor cannot be used because it is not related to service. This is a classic gotcha: the factor exists, but it cannot be linked to service. The only exception is factor 9(9) which explicitly addresses pre‑existence. Claimants must be careful to establish the service‑connection of the factor itself, not just the disease.

The dictionary defines “terminal event” for death cases. Only the listed events are covered; other causes of death (e.g., pancreatic cancer, suicide) are not included unless contributed to by pancreatitis. The SoP says “contributed to by the person’s chronic pancreatitis”, meaning the pancreatitis must be a contributing cause to the terminal event. If a person dies of a heart attack unrelated to pancreatitis, the death is not covered.

For a claimant, compliance means proving that at least one factor in section 9 exists and that the factor is related to relevant service. The process begins with collecting evidence of the factor. For smoking, the claimant should gather all available records of tobacco purchases, witness statements, and medical records that note smoking history. The best evidence is a detailed history recorded by a doctor early in the disease course. For alcohol, similar evidence is needed: hospital records with alcohol consumption notation, liver function tests, and self‑reports consistent with a pattern of heavy drinking. The formulaic calculation (90 kg = 9,000 standard drinks in five years) should be presented in a clear timeline.

Medical evidence must establish the date of clinical onset. A specialist gastroenterologist’s report should state when the patient first experienced symptoms consistent with chronic pancreatitis and when imaging showed changes. The report should also confirm that the condition meets the definition in section 7(2): progressive, irreversible morphological change with fibrosis. If the report uses a different classification, it may be rejected. The ICD‑10‑AM code is not determinative; the clinical definition controls. Claimants should ensure their doctor uses language matching the SoP.

For factor 9(3) (radiation), the claimant must locate records of the radiation course, including the dose, field, and date. The pancreas must have been in the field; a radiotherapy planning report should be obtained. For factors 9(4)‑(7) (obstruction, cholelithiasis, hyperparathyroidism, hypertriglyceridaemia), contemporaneous medical records from the time of onset are crucial. For hypertriglyceridaemia, lab results showing triglyceride levels above 11.3 mmol/L at the time of onset are needed. A single high reading may suffice, but it must be clearly temporally linked.

For factor 9(8) (acute pancreatitis), hospital discharge summaries for the acute episode should be obtained. The claimant must then link that episode to service under section 10. That may require a separate SoP for acute pancreatitis.

The relationship to service requirement in section 10 is often the hardest part. The claimant must show that the factor itself arose from service. For smoking, if the veteran started smoking after discharge, the factor will not be related unless the smoking was caused by a service‑related condition (e.g., PTSD). The claimant should provide evidence of a service‑related cause of heavy smoking or heavy drinking. If no such link exists, the factor fails regardless of the consumption level.

Factor 9(9) is an alternative. It applies only to material contribution to or aggravation of chronic pancreatitis that was already present before or during service but did not arise out of service. The claimant must prove that appropriate clinical management was not available due to service. This is a high bar: it requires evidence that the service environment (e.g., remote posting, lack of medical facilities) prevented proper treatment. Mere delay in diagnosis does not qualify unless it is due to service circumstances.

Claimants should also check for cross‑referenced SoPs under section 11. If a factor relies on another disease (e.g., acute pancreatitis, hyperparathyroidism, cholelithiasis), the claimant may need to satisfy the SoP for that disease. This means gathering evidence for multiple conditions.

Practitioners should maintain a checklist: (1) confirm the type of service (eligible war service, defence service, peacetime service) to ensure the SoP applies; (2) identify the relevant factor; (3) collect evidence of the factor and its timing; (4) collect evidence linking the factor to service; (5) obtain a medical report confirming the diagnosis and date of clinical onset; (6) calculate pack‑years or alcohol or other thresholds precisely; (7) consider whether the inability to obtain clinical management factor applies. If the claim is for death, obtain a death certificate and evidence that a terminal event occurred and that pancreatitis contributed to it.

Finally, compliance also involves being aware of the amendment history. The 2022 amendment changed the pack‑year definition; for claims made before 19 September 2022, the old definition may apply. For claims after, the new definition applies. The instrument is a compilation, but the commencement date of amendments is noted. Claimants should check the version in force at the time of their claim. The Legislation Register provides historical versions.